TCAR Surveillance Project

The TCAR Surveillance Project is designed to obtain more data about real-world outcomes of TCAR in comparison with CEA as performed by centers participating in the Vascular Quality Initiative (VQI). The TCAR Surveillance Project is directed by an SVS PSO Steering Committee that will make periodic analyses of data collected in the VQI CAS and CEA Registries.

The TCAR Surveillance Project was evaluated by the US Food and Drug Administration (FDA) and found scientifically valid and clinically relevant. Based on this, reimbursement for TCAR procedures performed by centers participating in the VQI TCAR Surveillance Project was approved on Sept. 1, 2016, by the Centers for Medicare and Medicaid Services (CMS) under the current National Coverage Determination.

June 2022 – Vascular Quality Initiative (SVS VQI) Announces the Expansion of Medicare Coverage to Standard Surgical Risk Patients within their TCAR Surveillance Project

TCAR Surveillance Project FAQs (updated June 2022)

TCAR Surveillance Project Expanded Indication Coverage Letter from CMS – May 2022

For more information on the TCAR Surveillance Project, please see the information and publications below:

Transcarotid artery revascularization versus transfemoral carotid artery stenting in the Society for Vascular Surgery Vascular Quality Initiative</a
(Malas MB1, Dakour-Aridi H2, Wang GJ3, Kashyap VS4, Motaganahalli RL5, Eldrup-Jorgensen J6, Cronenwett JL7, Schermerhorn ML8);
J Vasc Surg. 2018 Jun 13. pii: S0741-5214(18)31054-1. doi: 10.1016/j.jvs.2018.05.011.

Clinical Trials information on TCAR

Project Press Release – September 2016

Project Coverage Letter from CMS – August 2016